We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6808:HKEXSun Art Retail Group Limited Analysis

Data as of 2026-07-10 - not real-time

HK$1.07

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Sun Art Retail is trading well below its longer‑term moving averages, signaling a bearish price environment despite a modestly positive MACD histogram that hints at a potential short‑term reversal. The relative strength index sits in a neutral zone, while trading volume has been on a downtrend, suggesting waning market participation. Volatility remains elevated, and the stock’s beta is unusually low, indicating limited correlation with broader market moves. A strikingly high dividend yield tempts income seekers, yet the company posted a negative trailing earnings per share and a marginal operating margin, raising questions about dividend sustainability. The discounted cash‑flow model values the business at a level far above the current price, implying a sizable upside, but this is tempered by a recent revenue contraction and a negative profit margin. Analyst consensus leans toward a hold, with target prices still offering a meaningful premium to today’s level. Overall, the stock sits at the intersection of deep value appeal and earnings weakness, making the outlook contingent on a turnaround in profitability and cash generation.
Given the macro‑economic headwinds facing Chinese consumer retailers, the sector faces moderate risk, and regulatory scrutiny adds an additional layer of uncertainty. The company’s balance sheet shows moderate leverage, but the high payout ratio relative to earnings could strain cash flow if earnings do not improve. Investors should weigh the attractive dividend against the earnings deficit and consider the substantial upside potential against the heightened volatility and earnings risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish price positioning relative to longer‑term averages
  • High dividend yield offset by earnings deficit
  • Decreasing volume and elevated volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • DCF valuation indicating substantial upside
  • Improving forward earnings outlook
  • Attractive dividend yield if earnings recover

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Fundamental exposure to China’s consumer recovery
  • Persistent profitability challenges
  • Potential regulatory and macro‑economic headwinds

Key Metrics & Analysis

Financial Health

Revenue Growth-10.60%
Profit Margin-0.50%
P/E Ratio12.3
ROE-1.73%
ROA0.12%
Debt/Equity43.45
P/B Ratio0.5
Op. Cash FlowHK$634.0M
Free Cash FlowHK$3.1B

Technical Analysis

TrendBearish
RSI45.9
SupportHK$0.89
ResistanceHK$1.16
MA 20HK$1.03
MA 50HK$1.26
MA 200HK$1.60
MACDBullish
VolumeDecreasing
Fear & Greed Index94.59

Valuation

Fair ValueHK$4.49
Target PriceHK$1.65
Upside/Downside54.01%
GradeUndervalued
TypeValue
Dividend Yield16.04%

Risk Assessment

Beta0.08
Volatility83.87%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.